RFK-backed infant vaccine study in Africa to proceed despite backlash, U.S. says

A U.S.-backed study set to examine the overall health effects of hepatitis B vaccine dose timing on some 14,000 infants in the West African country of Guinea-Bissau has raised ethics concerns among scientists and former officials — and confusion amid conflicting reports on whether the research will...

Redirecting to full article...